Skip to main content

Table 2 In-hospital outcomes by acute kidney injury and renal replacement therapy status

From: Long-term outcomes in patients who received veno-venous extracorporeal membrane oxygenation and renal replacement therapy: a retrospective cohort study

Characteristica Overall, N = 300 AKI, RRT, N = 178 AKI, no RRT, N = 52 No AKI, N = 70
In-hospital mortality 65 (21.7%) 48 (27.0%) 6 (11.5%) 11 (15.7%)
ICU length of stay (days) 21 (14, 32) 24 (16, 38) 17 (11, 26) 19 (12, 32)
Hospital length of stay (days) 26 (17, 45) 27 (18, 47) 24 (15, 35) 28 (16, 46)
ECMO duration (days) 9 (6, 16) 10 (7, 16) 8 (6, 14) 8 (6, 18)
ECMO weaning 240 (80.0%) 133 (74.7%) 47 (90.4%) 60 (85.7%)
MV duration (days) 16 (10, 26) 18 (12, 29) 14 (9, 18) 12 (7, 25)
Sepsis 157 (52.3%) 102 (57.3%) 24 (46.2%) 31 (44.3%)
Bleeding 66 (22.0%) 49 (27.5%) 6 (11.5%) 11 (15.7%)
Stroke 42 (14.0%) 7 (13.5%) 30 (16.9%) 5 (7.1%)
Thrombosis 84 (28.0%) 53 (29.8%) 13 (25.0%) 18 (25.7%)
Total number of packed red blood cell units during ICU admission (n = 256)b 6 (3, 12) 9 (5, 17) 3 (2, 5) 4 (2, 8)
Total number of cryoprecipitate/FFP units during ICU admission (n = 86)b 6 (4, 13) 8 (4, 15) 2 (2, 6) 6 (4, 7)
Total number of platelets during ICU admission (n = 127)b 5 (3, 10) 5 (4, 11) 1 (1, 2) 4 (2, 6)
  1. AKI acute kidney injury, ECMO extracorporeal membrane oxygenation, FFP fresh frozen plasma, ICU intensive care unit, MV mechanical ventilation, RRT renal replacement therapy
  2. aStatistics presented: n (%), median (interquartile range)
  3. bExcluded those who did not receive blood products during admission